nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepenzolate—Ageusia—Captopril—systemic scleroderma	0.0287	0.0287	CcSEcCtD
Mepenzolate—Abdominal distension—Pentoxifylline—systemic scleroderma	0.0194	0.0194	CcSEcCtD
Mepenzolate—Ageusia—Mycophenolate mofetil—systemic scleroderma	0.0178	0.0178	CcSEcCtD
Mepenzolate—Drowsiness—Pentoxifylline—systemic scleroderma	0.0171	0.0171	CcSEcCtD
Mepenzolate—Erectile dysfunction—Captopril—systemic scleroderma	0.0134	0.0134	CcSEcCtD
Mepenzolate—Tension—Pentoxifylline—systemic scleroderma	0.0131	0.0131	CcSEcCtD
Mepenzolate—Nervousness—Pentoxifylline—systemic scleroderma	0.013	0.013	CcSEcCtD
Mepenzolate—Vision blurred—Pentoxifylline—systemic scleroderma	0.0126	0.0126	CcSEcCtD
Mepenzolate—Urinary retention—Mycophenolic acid—systemic scleroderma	0.0126	0.0126	CcSEcCtD
Mepenzolate—Palpitations—Pentoxifylline—systemic scleroderma	0.0118	0.0118	CcSEcCtD
Mepenzolate—Abdominal distension—Mycophenolic acid—systemic scleroderma	0.0115	0.0115	CcSEcCtD
Mepenzolate—Dry mouth—Pentoxifylline—systemic scleroderma	0.0112	0.0112	CcSEcCtD
Mepenzolate—Confusional state—Pentoxifylline—systemic scleroderma	0.011	0.011	CcSEcCtD
Mepenzolate—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.0109	0.0109	CcSEcCtD
Mepenzolate—Tachycardia—Pentoxifylline—systemic scleroderma	0.0107	0.0107	CcSEcCtD
Mepenzolate—Erectile dysfunction—Mycophenolic acid—systemic scleroderma	0.0106	0.0106	CcSEcCtD
Mepenzolate—Tension—Captopril—systemic scleroderma	0.00996	0.00996	CcSEcCtD
Mepenzolate—Urinary retention—Mycophenolate mofetil—systemic scleroderma	0.00995	0.00995	CcSEcCtD
Mepenzolate—Insomnia—Pentoxifylline—systemic scleroderma	0.00989	0.00989	CcSEcCtD
Mepenzolate—Nervousness—Captopril—systemic scleroderma	0.00986	0.00986	CcSEcCtD
Mepenzolate—Somnolence—Pentoxifylline—systemic scleroderma	0.00972	0.00972	CcSEcCtD
Mepenzolate—Dry mouth—Mometasone—systemic scleroderma	0.00963	0.00963	CcSEcCtD
Mepenzolate—Vision blurred—Captopril—systemic scleroderma	0.00957	0.00957	CcSEcCtD
Mepenzolate—Erectile dysfunction—Lisinopril—systemic scleroderma	0.0095	0.0095	CcSEcCtD
Mepenzolate—Anaphylactic shock—Mometasone—systemic scleroderma	0.00944	0.00944	CcSEcCtD
Mepenzolate—Constipation—Pentoxifylline—systemic scleroderma	0.00935	0.00935	CcSEcCtD
Mepenzolate—Abdominal distension—Mycophenolate mofetil—systemic scleroderma	0.0091	0.0091	CcSEcCtD
Mepenzolate—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00901	0.00901	CcSEcCtD
Mepenzolate—Palpitations—Captopril—systemic scleroderma	0.00897	0.00897	CcSEcCtD
Mepenzolate—Urticaria—Pentoxifylline—systemic scleroderma	0.00869	0.00869	CcSEcCtD
Mepenzolate—Dry mouth—Captopril—systemic scleroderma	0.00845	0.00845	CcSEcCtD
Mepenzolate—Confusional state—Captopril—systemic scleroderma	0.00836	0.00836	CcSEcCtD
Mepenzolate—Erectile dysfunction—Mycophenolate mofetil—systemic scleroderma	0.00833	0.00833	CcSEcCtD
Mepenzolate—Anaphylactic shock—Captopril—systemic scleroderma	0.00829	0.00829	CcSEcCtD
Mepenzolate—Tachycardia—Captopril—systemic scleroderma	0.00809	0.00809	CcSEcCtD
Mepenzolate—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00806	0.00806	CcSEcCtD
Mepenzolate—Vision blurred—Leflunomide—systemic scleroderma	0.00789	0.00789	CcSEcCtD
Mepenzolate—Asthenia—Pentoxifylline—systemic scleroderma	0.00785	0.00785	CcSEcCtD
Mepenzolate—Tension—Mycophenolic acid—systemic scleroderma	0.00783	0.00783	CcSEcCtD
Mepenzolate—Nervousness—Mycophenolic acid—systemic scleroderma	0.00775	0.00775	CcSEcCtD
Mepenzolate—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00752	0.00752	CcSEcCtD
Mepenzolate—Insomnia—Captopril—systemic scleroderma	0.0075	0.0075	CcSEcCtD
Mepenzolate—Palpitations—Leflunomide—systemic scleroderma	0.0074	0.0074	CcSEcCtD
Mepenzolate—Somnolence—Captopril—systemic scleroderma	0.00737	0.00737	CcSEcCtD
Mepenzolate—Dizziness—Pentoxifylline—systemic scleroderma	0.00723	0.00723	CcSEcCtD
Mepenzolate—Constipation—Captopril—systemic scleroderma	0.00709	0.00709	CcSEcCtD
Mepenzolate—Tension—Lisinopril—systemic scleroderma	0.00706	0.00706	CcSEcCtD
Mepenzolate—Palpitations—Mycophenolic acid—systemic scleroderma	0.00706	0.00706	CcSEcCtD
Mepenzolate—Nervousness—Lisinopril—systemic scleroderma	0.00698	0.00698	CcSEcCtD
Mepenzolate—Dry mouth—Leflunomide—systemic scleroderma	0.00697	0.00697	CcSEcCtD
Mepenzolate—Vomiting—Pentoxifylline—systemic scleroderma	0.00695	0.00695	CcSEcCtD
Mepenzolate—Headache—Pentoxifylline—systemic scleroderma	0.00685	0.00685	CcSEcCtD
Mepenzolate—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00683	0.00683	CcSEcCtD
Mepenzolate—Feeling abnormal—Captopril—systemic scleroderma	0.00683	0.00683	CcSEcCtD
Mepenzolate—Vision blurred—Lisinopril—systemic scleroderma	0.00678	0.00678	CcSEcCtD
Mepenzolate—Asthenia—Mometasone—systemic scleroderma	0.00677	0.00677	CcSEcCtD
Mepenzolate—Tachycardia—Leflunomide—systemic scleroderma	0.00667	0.00667	CcSEcCtD
Mepenzolate—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00665	0.00665	CcSEcCtD
Mepenzolate—Confusional state—Mycophenolic acid—systemic scleroderma	0.00657	0.00657	CcSEcCtD
Mepenzolate—Nausea—Pentoxifylline—systemic scleroderma	0.0065	0.0065	CcSEcCtD
Mepenzolate—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00636	0.00636	CcSEcCtD
Mepenzolate—Palpitations—Lisinopril—systemic scleroderma	0.00635	0.00635	CcSEcCtD
Mepenzolate—Tension—Mycophenolate mofetil—systemic scleroderma	0.00618	0.00618	CcSEcCtD
Mepenzolate—Insomnia—Leflunomide—systemic scleroderma	0.00618	0.00618	CcSEcCtD
Mepenzolate—Abdominal distension—Prednisone—systemic scleroderma	0.00617	0.00617	CcSEcCtD
Mepenzolate—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00612	0.00612	CcSEcCtD
Mepenzolate—Vomiting—Mometasone—systemic scleroderma	0.006	0.006	CcSEcCtD
Mepenzolate—Dry mouth—Lisinopril—systemic scleroderma	0.00599	0.00599	CcSEcCtD
Mepenzolate—Feeling abnormal—Azathioprine—systemic scleroderma	0.00596	0.00596	CcSEcCtD
Mepenzolate—Asthenia—Captopril—systemic scleroderma	0.00595	0.00595	CcSEcCtD
Mepenzolate—Confusional state—Lisinopril—systemic scleroderma	0.00592	0.00592	CcSEcCtD
Mepenzolate—Headache—Mometasone—systemic scleroderma	0.00591	0.00591	CcSEcCtD
Mepenzolate—Insomnia—Mycophenolic acid—systemic scleroderma	0.00589	0.00589	CcSEcCtD
Mepenzolate—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00587	0.00587	CcSEcCtD
Mepenzolate—Constipation—Leflunomide—systemic scleroderma	0.00584	0.00584	CcSEcCtD
Mepenzolate—Somnolence—Mycophenolic acid—systemic scleroderma	0.00579	0.00579	CcSEcCtD
Mepenzolate—Tachycardia—Lisinopril—systemic scleroderma	0.00573	0.00573	CcSEcCtD
Mepenzolate—Erectile dysfunction—Prednisone—systemic scleroderma	0.00565	0.00565	CcSEcCtD
Mepenzolate—Feeling abnormal—Leflunomide—systemic scleroderma	0.00563	0.00563	CcSEcCtD
Mepenzolate—Nausea—Mometasone—systemic scleroderma	0.0056	0.0056	CcSEcCtD
Mepenzolate—Constipation—Mycophenolic acid—systemic scleroderma	0.00557	0.00557	CcSEcCtD
Mepenzolate—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00557	0.00557	CcSEcCtD
Mepenzolate—Dizziness—Captopril—systemic scleroderma	0.00548	0.00548	CcSEcCtD
Mepenzolate—Urticaria—Leflunomide—systemic scleroderma	0.00543	0.00543	CcSEcCtD
Mepenzolate—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00537	0.00537	CcSEcCtD
Mepenzolate—Hypersensitivity—Azathioprine—systemic scleroderma	0.00533	0.00533	CcSEcCtD
Mepenzolate—Insomnia—Lisinopril—systemic scleroderma	0.00531	0.00531	CcSEcCtD
Mepenzolate—Vomiting—Captopril—systemic scleroderma	0.00527	0.00527	CcSEcCtD
Mepenzolate—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00525	0.00525	CcSEcCtD
Mepenzolate—Somnolence—Lisinopril—systemic scleroderma	0.00522	0.00522	CcSEcCtD
Mepenzolate—Headache—Captopril—systemic scleroderma	0.00519	0.00519	CcSEcCtD
Mepenzolate—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00518	0.00518	CcSEcCtD
Mepenzolate—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00514	0.00514	CcSEcCtD
Mepenzolate—Hypersensitivity—Leflunomide—systemic scleroderma	0.00503	0.00503	CcSEcCtD
Mepenzolate—Constipation—Lisinopril—systemic scleroderma	0.00502	0.00502	CcSEcCtD
Mepenzolate—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00502	0.00502	CcSEcCtD
Mepenzolate—Nausea—Captopril—systemic scleroderma	0.00492	0.00492	CcSEcCtD
Mepenzolate—Asthenia—Leflunomide—systemic scleroderma	0.0049	0.0049	CcSEcCtD
Mepenzolate—Feeling abnormal—Lisinopril—systemic scleroderma	0.00484	0.00484	CcSEcCtD
Mepenzolate—Dizziness—Azathioprine—systemic scleroderma	0.00478	0.00478	CcSEcCtD
Mepenzolate—Erectile dysfunction—Methotrexate—systemic scleroderma	0.00472	0.00472	CcSEcCtD
Mepenzolate—Asthenia—Mycophenolic acid—systemic scleroderma	0.00467	0.00467	CcSEcCtD
Mepenzolate—Urticaria—Lisinopril—systemic scleroderma	0.00466	0.00466	CcSEcCtD
Mepenzolate—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00465	0.00465	CcSEcCtD
Mepenzolate—Vomiting—Azathioprine—systemic scleroderma	0.0046	0.0046	CcSEcCtD
Mepenzolate—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00457	0.00457	CcSEcCtD
Mepenzolate—Drowsiness—Methotrexate—systemic scleroderma	0.00457	0.00457	CcSEcCtD
Mepenzolate—Headache—Azathioprine—systemic scleroderma	0.00453	0.00453	CcSEcCtD
Mepenzolate—Dizziness—Leflunomide—systemic scleroderma	0.00452	0.00452	CcSEcCtD
Mepenzolate—Constipation—Mycophenolate mofetil—systemic scleroderma	0.0044	0.0044	CcSEcCtD
Mepenzolate—Vomiting—Leflunomide—systemic scleroderma	0.00434	0.00434	CcSEcCtD
Mepenzolate—Hypersensitivity—Lisinopril—systemic scleroderma	0.00432	0.00432	CcSEcCtD
Mepenzolate—Dizziness—Mycophenolic acid—systemic scleroderma	0.00431	0.00431	CcSEcCtD
Mepenzolate—Nausea—Azathioprine—systemic scleroderma	0.0043	0.0043	CcSEcCtD
Mepenzolate—Headache—Leflunomide—systemic scleroderma	0.00428	0.00428	CcSEcCtD
Mepenzolate—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00424	0.00424	CcSEcCtD
Mepenzolate—Asthenia—Lisinopril—systemic scleroderma	0.00421	0.00421	CcSEcCtD
Mepenzolate—Vomiting—Mycophenolic acid—systemic scleroderma	0.00414	0.00414	CcSEcCtD
Mepenzolate—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00408	0.00408	CcSEcCtD
Mepenzolate—Headache—Mycophenolic acid—systemic scleroderma	0.00408	0.00408	CcSEcCtD
Mepenzolate—Nausea—Leflunomide—systemic scleroderma	0.00406	0.00406	CcSEcCtD
Mepenzolate—Vision blurred—Prednisone—systemic scleroderma	0.00402	0.00402	CcSEcCtD
Mepenzolate—Dizziness—Lisinopril—systemic scleroderma	0.00388	0.00388	CcSEcCtD
Mepenzolate—Nausea—Mycophenolic acid—systemic scleroderma	0.00387	0.00387	CcSEcCtD
Mepenzolate—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00379	0.00379	CcSEcCtD
Mepenzolate—Vomiting—Lisinopril—systemic scleroderma	0.00373	0.00373	CcSEcCtD
Mepenzolate—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00369	0.00369	CcSEcCtD
Mepenzolate—Headache—Lisinopril—systemic scleroderma	0.00368	0.00368	CcSEcCtD
Mepenzolate—Nausea—Lisinopril—systemic scleroderma	0.00349	0.00349	CcSEcCtD
Mepenzolate—Anaphylactic shock—Prednisone—systemic scleroderma	0.00349	0.00349	CcSEcCtD
Mepenzolate—Tachycardia—Prednisone—systemic scleroderma	0.0034	0.0034	CcSEcCtD
Mepenzolate—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.0034	0.0034	CcSEcCtD
Mepenzolate—Vision blurred—Methotrexate—systemic scleroderma	0.00336	0.00336	CcSEcCtD
Mepenzolate—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00327	0.00327	CcSEcCtD
Mepenzolate—Headache—Mycophenolate mofetil—systemic scleroderma	0.00322	0.00322	CcSEcCtD
Mepenzolate—Insomnia—Prednisone—systemic scleroderma	0.00315	0.00315	CcSEcCtD
Mepenzolate—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00305	0.00305	CcSEcCtD
Mepenzolate—Constipation—Prednisone—systemic scleroderma	0.00298	0.00298	CcSEcCtD
Mepenzolate—Confusional state—Methotrexate—systemic scleroderma	0.00294	0.00294	CcSEcCtD
Mepenzolate—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00291	0.00291	CcSEcCtD
Mepenzolate—Feeling abnormal—Prednisone—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Mepenzolate—Urticaria—Prednisone—systemic scleroderma	0.00277	0.00277	CcSEcCtD
Mepenzolate—Insomnia—Methotrexate—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Mepenzolate—Somnolence—Methotrexate—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Mepenzolate—Hypersensitivity—Prednisone—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Mepenzolate—Asthenia—Prednisone—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Mepenzolate—Feeling abnormal—Methotrexate—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Mepenzolate—Urticaria—Methotrexate—systemic scleroderma	0.00231	0.00231	CcSEcCtD
Mepenzolate—Dizziness—Prednisone—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Mepenzolate—Vomiting—Prednisone—systemic scleroderma	0.00222	0.00222	CcSEcCtD
Mepenzolate—Headache—Prednisone—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Mepenzolate—Hypersensitivity—Methotrexate—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Mepenzolate—Asthenia—Methotrexate—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Mepenzolate—Nausea—Prednisone—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Mepenzolate—Dizziness—Methotrexate—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Mepenzolate—Vomiting—Methotrexate—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Mepenzolate—Headache—Methotrexate—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Mepenzolate—Nausea—Methotrexate—systemic scleroderma	0.00173	0.00173	CcSEcCtD
